Aaron Royston
Director/Board Member presso Neurogastrx, Inc.
Profilo
Aaron E.
Royston is the founder of Red Ventures LLC (founded in 2010) and Rayzebio, Inc. (founded in 2020).
At Rayzebio, Inc., he held the title of Director from 2020 to 2023.
Currently, Dr. Royston serves as a Board of Directors at HistoWiz, Inc. since 2021 and as a Board Of Director at Swift Health Systems, Inc. since 2019.
He is also a Director at Neurogastrx, Inc., Ablaze Pharmaceuticals, Ceptur Therapeutics, Inc., Attovia Therapeutics, and venBio Partners LLC.
In his former positions, Dr. Royston was a Director at Ipi Legacy Liquidation Co. from 2016 to 2021, an Independent Director at Menlo Therapeutics, Inc. from 2017 to 2019, and an Independent Non-Executive Director at Akero Therapeutics, Inc. from 2018 to 2019.
He also served as a Director at Harmony Biosciences Holdings, Inc., Harmony Biosciences LLC, Ventyx Biosciences, Inc., and Apellis Pharmaceuticals, Inc.Dr. Royston completed his undergraduate degree at Duke University and holds an MBA and a doctorate from the University of Pennsylvania.
Posizioni attive di Aaron Royston
Società | Posizione | Inizio |
---|---|---|
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Director/Board Member | 04/01/2018 |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | Director/Board Member | - |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Director/Board Member | - |
35Pharma, Inc.
35Pharma, Inc. Pharmaceuticals: MajorHealth Technology 35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov. | Director/Board Member | 01/11/2022 |
HistoWiz, Inc.
HistoWiz, Inc. Packaged SoftwareTechnology Services HistoWiz, Inc. develops information technology infrastructure to archive and manage multi-terabyte databases for histopathology services. It offers PathologyMap, an online preclinical pathology database allowing online viewing, tagging, collaboration, search, comparison, and analysis of histopathology data across different laboratories and hospitals. The company was founded by Ke Cheng in 2012 and is headquartered in Brooklyn, NY. | Director/Board Member | 01/10/2021 |
Swift Health Systems, Inc.
Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Swift Health Systems, Inc. provides healthcare services. It offers dental solutions. The company was founded by John Pham and Hongsheng Tong in 2014 and is headquartered in Irvine, CA. | Director/Board Member | 07/01/2019 |
Attovia Therapeutics
Attovia Therapeutics Medical SpecialtiesHealth Technology Attovia Therapeutics manufactures a pipeline for bio therapeutics to immune-mediated diseases including cancer. The company is based in Sacramento, CA. Attovia Therapeutics was founded by Tao Fu and Tao Fu has been the CEO since incorporation. | Director/Board Member | - |
Precedenti posizioni note di Aaron Royston
Società | Posizione | Fine |
---|---|---|
RAYZEBIO, INC. | Founder | 01/11/2023 |
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Aaron Royston
Duke University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 6 |
---|---|
IPI LEGACY LIQUIDATION CO | Health Technology |
APELLIS PHARMACEUTICALS, INC. | Health Technology |
HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
AKERO THERAPEUTICS, INC. | Health Technology |
VENTYX BIOSCIENCES, INC. | Health Technology |
RAYZEBIO, INC. | Health Technology |
Aziende private | 11 |
---|---|
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
HistoWiz, Inc.
HistoWiz, Inc. Packaged SoftwareTechnology Services HistoWiz, Inc. develops information technology infrastructure to archive and manage multi-terabyte databases for histopathology services. It offers PathologyMap, an online preclinical pathology database allowing online viewing, tagging, collaboration, search, comparison, and analysis of histopathology data across different laboratories and hospitals. The company was founded by Ke Cheng in 2012 and is headquartered in Brooklyn, NY. | Technology Services |
Red Ventures LLC
Red Ventures LLC Advertising/Marketing ServicesCommercial Services Red Ventures LLC engages in the development of an online digital consumer platform. It brings consumers and brands together through the use of online marketplaces and strategic partnerships. It serves the healthcare, home services, and financial services industries. The company was founded by Ricardo Luis Elias and Daniel S. Feldstein in 2000 and is headquartered in Fort Mill, SC. | Commercial Services |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Finance |
Swift Health Systems, Inc.
Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Swift Health Systems, Inc. provides healthcare services. It offers dental solutions. The company was founded by John Pham and Hongsheng Tong in 2014 and is headquartered in Irvine, CA. | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | Health Technology |
Ceptur Therapeutics, Inc.
Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Health Technology |
35Pharma, Inc.
35Pharma, Inc. Pharmaceuticals: MajorHealth Technology 35Pharma, Inc. designs and develops biologics for diseases of high unmet medical need. The CEO of the Canadian company is Ilia A. Tikhomirov. | Health Technology |
Attovia Therapeutics
Attovia Therapeutics Medical SpecialtiesHealth Technology Attovia Therapeutics manufactures a pipeline for bio therapeutics to immune-mediated diseases including cancer. The company is based in Sacramento, CA. Attovia Therapeutics was founded by Tao Fu and Tao Fu has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Aaron Royston